Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Yaohua Medical Instrument Inks Agreement for Cervical Cancer Scan in China

publication date: Jan 27, 2017
China’s Shandong Yaohua Medical Instrument has in-licensed exclusive Greater China rights to  the LuViva® Advanced Cervical Scan from Guided Therapeutics. Guided is an Atlanta-based maker of rapid tests based on its patented biophotonic technology. In addition to an earlier payment of $50,000, Shandong Yaohua will pay a $1 million license fee and buy a minimum of ten LuViva® Advanced Cervical Scan devices in 2017, plus pay royalties for disposables. In return, Guided will issue $1 million in common stock to Yaohua. Yaohua will manufacture the device for itself and for Guided's global use. More details....

Stock Symbol: (OTCQB: GTHP)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital